(Q44826356)

6 December 2017

title

Risk of multiple sclerosis following clinically isolated syndrome: a 4-year prospective study (English)

1 reference

clinically isolated syndrome

6 December 2017

main subject

1 reference

2

1 reference

6 December 2017

3

1 reference

6 December 2017

4

1 reference

6 December 2017

Maria Donata Benedetti

object named as

Maria Donata Benedetti

15

0 references

Maurizio Leone

object named as

Maurizio Leone

16

0 references

author name string

Roberto D'Alessandro

1

1 reference

6 December 2017

Franco Granella

5

1 reference

6 December 2017

Maria Rosaria Tola

6

1 reference

6 December 2017

Susanna Malagù

7

1 reference

6 December 2017

Luisa Motti

8

1 reference

6 December 2017

Walter Neri

9

1 reference

6 December 2017

Massimo Galeotti

10

1 reference

6 December 2017

Mario Santangelo

11

1 reference

6 December 2017

Laila Fiorani

12

1 reference

6 December 2017

Enrico Montanari

13

1 reference

6 December 2017

Cinzia Scandellari

14

1 reference

6 December 2017

publication date

3 February 2013

1 reference

6 December 2017

1 reference

6 December 2017

volume

260

1 reference

6 December 2017

issue

6

1 reference

6 December 2017

page(s)

1583-1593

1 reference

Conversion to multiple sclerosis after a clinically isolated syndrome of the brainstem: cranial magnetic resonance imaging, cerebrospinal fluid and neurophysiological findings.

6 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS00415-013-6838-X

Clinically isolated syndromes suggestive of multiple sclerosis, part I: natural history, pathogenesis, diagnosis, and prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-013-6838-X

Interferon beta-1a for early multiple sclerosis: CHAMPS trial subgroup analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-013-6838-X

New diagnostic criteria for multiple sclerosis: guidelines for research protocols

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-013-6838-X

Brainstem lesions in clinically isolated syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-013-6838-X

A prospective study on the predictive value of CSF oligoclonal bands and MRI in acute isolated neurological syndromes for subsequent progression to multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-013-6838-X

Will Rogers phenomenon in multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-013-6838-X

The significance of brain magnetic resonance imaging abnormalities at presentation with clinically isolated syndromes suggestive of multiple sclerosis. A 5-year follow-up study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-013-6838-X

Effect of early interferon treatment on conversion to definite multiple sclerosis: a randomised study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-013-6838-X

Treatment with interferon beta-1b delays conversion to clinically definite and McDonald MS in patients with clinically isolated syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-013-6838-X

Comparison of two dosing frequencies of subcutaneous interferon beta-1a in patients with a first clinical demyelinating event suggestive of multiple sclerosis (REFLEX): a phase 3 randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-013-6838-X

Effect of glatiramer acetate on conversion to clinically definite multiple sclerosis in patients with clinically isolated syndrome (PreCISe study): a randomised, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-013-6838-X

MRI criteria for dissemination in space in patients with clinically isolated syndromes: a multicentre follow-up study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-013-6838-X

MRI only conversion to multiple sclerosis following a clinically isolated syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-013-6838-X

Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS)

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-013-6838-X

Concurrent validity of the MS Functional Composite using MRI as a biological disease marker

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-013-6838-X

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-013-6838-X

Diagnostic criteria for multiple sclerosis: 2005 revisions to the “McDonald Criteria”

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-013-6838-X

Comparison of MRI criteria at first presentation to predict conversion to clinically definite multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-013-6838-X

Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-013-6838-X

Baseline MRI predicts future attacks and disability in clinically isolated syndromes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-013-6838-X

Early cognitive impairment in patients with clinically isolated syndrome suggestive of multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-013-6838-X

Effect of the disclosure of MS diagnosis on anxiety, mood and quality of life of patients: a prospective study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-013-6838-X

A three-year, multi-parametric MRI study in patients at presentation with CIS

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-013-6838-X

Isolated demyelinating syndromes: comparison of different MR imaging criteria to predict conversion to clinically definite multiple sclerosis

21 January 2018

1 reference

12 December 2020

Oligoclonal bands and MRI in clinically isolated syndromes: predicting conversion time to multiple sclerosis

1 reference

12 December 2020

The multiple sclerosis functional composite: different practice effects in the three test components

1 reference

12 December 2020

The Multiple Sclerosis Functional Composite Measure (MSFC): an integrated approach to MS clinical outcome assessment. National MS Society Clinical Outcomes Assessment Task Force

1 reference

12 December 2020

10.1007/S00415-013-6838-X

Identifiers

DOI

1 reference

6 December 2017

1 reference